The Effect of Pulmonary Rehabilitation on Bronchoscopic Volume Reduction Process Success

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04347044

Enrollment

Registered

2020-04-15

Start date

2013-01-01

Completion date

2020-08-18

Last updated

2020-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emphysema, Pulmonary Rehabilitation, Bronchoscopic Lung Volume Reduction

Brief summary

The data of patients undergoing bronchoscopic volume reduction procedure will be analyzed retrospectively. Patients will be divided into two groups as patients with and without Pulmonary Rehabilitation before the procedure, and changes in functional levels of patients will be compared.

Detailed description

The data of patients who underwent bronchoscopic volume reduction between January 2013 and March 2019 will be examined. Patients will be divided into two groups as pulmonary rehabilitation applied (PR group) and not applied (Control group) before the procedure. Changes in the parameters of initial and rehabilitation follow-up will be examined.

Interventions

OTHERPulmonary Rehabilitation

Exercise training+ Optimal medication and clinical follow-up

OTHERStandart care

Optimal medication and clinical follow-up

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Between the ages of 18-75 * Patients with a diagnosis of emphysema and bronchoscopic procedures

Exclusion criteria

• Patients who develop complications related to the procedure after bronchoscopic procedure.

Design outcomes

Primary

Measure	Time frame	Description
Six minute walking test	20 minutes	The test was conducted in a 30-meter corridor in line with American Thoracic Society (ATS) guidelines. Patients were asked to walk as far as they can. Prior to and following the test, oxygen saturation, heart rate and Borg fatigue rating were measured, and the walking distance were recorded
Pulmonary Function Tests	15 minutes	PFTs were performed by using the Sensormedics model 2400 (Yorba Linda, CA, USA) spirometry device, and according to the American Thoracic Society (ATS) guidelines

Secondary

Measure	Time frame	Description
Carbonmonoxide diffusion test	15 minutes	It will performed in the pulmonary function test laboratory using Cosmed Quark PFT (USA) with single-breath technique

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026